CORTEVA INC (CTVA)

US22052L1044 - Common Stock

60.76  +2 (+3.4%)

After market: 60.76 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to CTVA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 64.92. This target is 6.85% above the current price.
CTVA was analyzed by 30 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CTVA.
In the previous month the buy percentage consensus was at a similar level.
CTVA was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 60.7655.5566.3064.9273.50 - -8.57% 9.12% 6.85% 20.97%
Up and Down Grades
Date Firm Action Rating
2024-11-21 Keybanc Maintains Overweight -> Overweight
2024-11-20 Wells Fargo Maintains Overweight -> Overweight
2024-11-20 B of A Securities Maintains Buy -> Buy
2024-11-11 RBC Capital Maintains Outperform -> Outperform
2024-11-08 Oppenheimer Reiterate Outperform -> Outperform
2024-11-08 Barclays Maintains Equal-Weight -> Equal-Weight
2024-11-07 UBS Maintains Buy -> Buy
2024-10-23 Citigroup Initiate Buy
2024-10-16 B of A Securities Upgrade Neutral -> Buy
2024-09-24 Morgan Stanley Maintains Overweight -> Overweight
2024-08-07 Argus Research Downgrade Buy -> Hold
2024-08-02 Keybanc Maintains Overweight -> Overweight
2024-08-02 Wells Fargo Maintains Overweight -> Overweight
2024-08-02 JP Morgan Maintains Neutral -> Neutral
2024-06-18 Mizuho Maintains Buy -> Buy
2024-06-12 Deutsche Bank Maintains Buy -> Buy
2024-06-07 OTR Global Downgrade Mixed -> Negative
2024-05-06 Deutsche Bank Maintains Buy -> Buy
2024-05-06 RBC Capital Maintains Outperform -> Outperform
2024-05-03 BMO Capital Maintains Outperform -> Outperform
2024-05-03 Oppenheimer Maintains Outperform -> Outperform
2024-05-03 Wells Fargo Maintains Overweight -> Overweight
2024-05-03 Canaccord Genuity Maintains Buy -> Buy
2024-05-02 Mizuho Maintains Buy -> Buy
2024-04-16 Oppenheimer Maintains Outperform -> Outperform
2024-04-12 JP Morgan Downgrade Overweight -> Neutral
2024-04-10 Barclays Maintains Equal-Weight -> Equal-Weight
2024-04-09 Keybanc Maintains Overweight -> Overweight
2024-03-01 Wolfe Research Initiate Outperform
2024-02-12 Loop Capital Upgrade Hold -> Buy